These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3545279)

  • 1. Anti-granulocyte opsonic activity in sera from patients with systemic lupus erythematosus.
    Hadley AG; Byron MA; Chapel HM; Bunch C; Holburn AM
    Br J Haematol; 1987 Jan; 65(1):61-5. PubMed ID: 3545279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-granulocyte opsonic activity and autoimmune neutropenia.
    Hadley AG; Holburn AM; Bunch C; Chapel H
    Br J Haematol; 1986 Jul; 63(3):581-9. PubMed ID: 3524659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective evaluation of the chemiluminescence test for the detection of granulocyte antibodies: comparison with the granulocyte immunofluorescence test.
    Lucas GF
    Vox Sang; 1994; 66(2):141-7. PubMed ID: 8184597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic studies of phagocytosis. III. The complement-dependent opsonic and anti-opsonic effects of normal and sle sera.
    Håkansson L; Hällgren R; Venge P
    Immunology; 1982 Sep; 47(1):91-9. PubMed ID: 6981589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil-binding immunoglobulin G in systemic lupus erythematosus.
    Starkebaum G; Arend WP
    J Clin Invest; 1979 Oct; 64(4):902-12. PubMed ID: 479375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune neutropenia in systemic lupus erythematosus.
    Starkebaum G; Price TH; Lee MY; Arend WP
    Arthritis Rheum; 1978 Jun; 21(5):504-12. PubMed ID: 666871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum heat-labile opsonins in systemic lupus erythematosus.
    Jasin HE; Orozco JH; Ziff M
    J Clin Invest; 1974 Feb; 53(2):343-53. PubMed ID: 11344546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T lymphocyte interaction with immunoglobulin G antibody in systemic lupus erythematosus.
    Okudaira K; Searles RP; Tanimoto K; Horiuchi Y; Williams RC
    J Clin Invest; 1982 Apr; 69(4):1026-38. PubMed ID: 6978891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The detection of anti-granulocyte antibodies by chemiluminescence.
    Hadley A; Holburn AM
    Clin Lab Haematol; 1984; 6(4):351-61. PubMed ID: 6525802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement-activating antineutrophil antibody in systemic lupus erythematosus.
    Rustagi PK; Currie MS; Logue GL
    Am J Med; 1985 Jun; 78(6 Pt 1):971-7. PubMed ID: 4014272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin phagocytosis by granulocytes from sera and synovial fluids in various rheumatoid and nonrheumatoid diseases.
    Cats A; Lafeber GJ; Klein F
    Ann Rheum Dis; 1975 Apr; 34(2):146-55. PubMed ID: 806270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
    Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R
    J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus.
    Cines DB; Lyss AP; Reeber M; Bina M; DeHoratius RJ
    J Clin Invest; 1984 Mar; 73(3):611-25. PubMed ID: 6368583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired degradation and aberrant phagocytosis of necrotic cell debris in the peripheral blood of patients with primary Sjögren's syndrome.
    Fragoulis GE; Vakrakou AG; Papadopoulou A; Germenis A; Kanavakis E; Moutsopoulos HM; Manoussakis MN
    J Autoimmun; 2015 Jan; 56():12-22. PubMed ID: 25228497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of interferon-gamma-treated U937 cells in chemiluminescence assays to detect red cell, platelet and granulocyte antibodies of potential clinical significance.
    Hadley AG; Poole GD; Amphlett NW; Lucas GF
    Clin Lab Haematol; 1992; 14(4):315-26. PubMed ID: 1478011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigranulocyte antibodies in patients with systemic lupus erythematosus (SLE).
    Sipos A; Seres T; Szegedi G
    Acta Med Hung; 1987; 44(4):299-310. PubMed ID: 3444710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies against granulocyte colony-stimulating factor in Felty's syndrome and neutropenic systemic lupus erythematosus.
    Hellmich B; Csernok E; Schatz H; Gross WL; Schnabel A
    Arthritis Rheum; 2002 Sep; 46(9):2384-91. PubMed ID: 12355486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemiluminescence of whole blood. 1. A simple and rapid method for the estimation of phagocytic function of granulocytes and opsonic activity in whole blood.
    Tono-Oka T; Ueno N; Matsumoto T; Ohkawa M; Matsumoto S
    Clin Immunol Immunopathol; 1983 Jan; 26(1):66-75. PubMed ID: 6191898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opsonic activity of myeloma immunoglobulins (MM-Ig).
    Cheson BD
    Am J Hematol; 1981 Dec; 11(4):347-53. PubMed ID: 7331990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on anti-granulocyte and anti-platelet antibodies in patients with systemic sclerosis. Chemotaxis, phagocytosis and opsonized effect of PSS sera on normal granulocytes.
    Sipos A; Czirják L; Lörincz G; Szegedi G
    Scand J Rheumatol; 1988; 17(1):43-50. PubMed ID: 3368751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.